Proactive Investors UK |
Angle PLC: Parsortix enables analysis in head and neck cancer
Marketwired (press release) The University of Athens work suggest that, for the first time, it might be possible to assess gene expression of head and neck cancers using a Parsortix non-invasive liquid biopsy. Gene expression of biomarkers such as PD-L1 provides key information ... ANGLE: Latest data burnishes credential of breakthrough cancer diagnosticProactive Investors UK all 2 news articles » |
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2oQ4YjK
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου